<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation-group" /><meta name="keywords" content="Sevikar preparations; Amlodipine: olmesartan with; Olmesartan: amlodipine with" /><meta name="IX" content="Sevikar preparations; Amlodipine: olmesartan with; Olmesartan: amlodipine with" /><title>With calcium-channel blocker: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="202472.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="202472.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=202472.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1002.htm">2 Cardiovascular system</a> &gt; <a href="2534.htm">2.5 Hypertension and heart failure</a> &gt; <a href="27510.htm">2.5.5 Drugs affecting the renin-angiotensin system</a> &gt; <a href="27513.htm">2.5.5.2 Angiotensin-II receptor antagonists</a> &gt; <a href="127965.htm">OLMESARTAN MEDOXOMIL</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="27526.htm" title="Previous: LOSARTAN POTASSIUM">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="81217.htm" title="Next: TELMISARTAN">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a302020.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Olmesartan Medoxomil</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Cardiovascular Drugs 24:00 &gt; Renin-Angiotensin-Aldosterone System Inhibitors 24:32 &gt; Angiotensin II Receptor Antagonists 24:32.08</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/7978-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Olmesartan</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: O &gt; Interactions of Olmesartan</p></div></li></ul><ul><li><h3>British National Formulary (6)</h3></li><li><a href="27513.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.5.5.2 Angiotensin-II receptor antagonists</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.5 Drugs affecting the renin-angiotensin system</p></div></li><li><a href="127965.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">OLMESARTAN MEDOXOMIL</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.2 Angiotensin-II receptor antagonists</p></div></li><li><a href="127966.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Olmetec®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.5 Hypertension and heart failure &gt; 2.5.5 Drugs affecting the renin-angiotensin system &gt; 2.5.5.2 Angiotensin-II receptor antagonists &gt; OLMESARTAN MEDOXOMIL</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22olmesartan+medoxomil%22%22olmesartan%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK-TD-c87-mn0001-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Olmesartan</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; O</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0014s0018.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Olmesartan Medoxomil</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/20222-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Olmesartan Medoxomil</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/06839.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Olmesartan</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; O &gt; OL</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D797.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Olmesartan</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; O</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c280.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Olmesartan medoxomil</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; O</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_127965">OLMESARTAN MEDOXOMIL</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i966.htm" title="Go to appendix 1">Olmesartan</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">hypertension (see also notes above)</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see <a title="target-block: A-II rec antag cautions" href="27513.htm#_27513.1">notes above</a></p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">biliary obstruction</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">dose should not exceed 20 mg daily in moderate impairment;
manufacturer advises avoid in severe impairment—no information available</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">max. 20 mg daily if eGFR 20–60 mL/minute/1.73 m<sup>2</sup>; avoid if eGFR less than 20 mL/minute/1.73 m<sup>2</sup></p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">see <a title="BNF:target-block: Angiotensin II receptor antagonists in pregnancy" href="27513.htm#_204167">notes above</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">see <a title="BNF:target-block: Angiotensin II receptor antagonists in breast-feeding" href="27513.htm#_204168">notes above</a></p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see notes above; also gastro-intestinal disturbances;
chest pain, peripheral oedema, hypertriglyceridaemia; fatigue; influenza-like
symptoms, cough, pharyngitis, rhinitis; urinary-tract infection; haematuria,
hyperuricaemia; arthritis, musculoskeletal pain; <i>less commonly</i> angina, vertigo, rash; <i>very rarely</i> headache, thrombocytopenia,
myalgia, pruritus, urticaria</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Initially 10 mg once daily; if necessary increased to
20 mg once daily; max. 40 mg daily</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="127966.htm#_127966" title="Olmetec®">Olmetec®</a></li><li class="jN" id="_202472" style="margin: 0 0 0 20px;"><h1 class="title">With calcium-channel blocker</h1><div class="cAR"><h3>Note</h3> <p class="cAX">For hypertension in patients stabilised on
the individual components in the same proportions. For prescribing
information on amlodipine, see <a title="BNF:monograph: AMLODIPINE" href="2671.htm#_2671">section 2.6.2</a></p></div><ul><li><a href="202473.htm#_202473" title="Sevikar®">Sevikar®</a></li></ul></li><li id="_218763__218763"><a href="218763.htm#_218763" title="With calcium-channel blocker and diuretic">With calcium-channel blocker and diuretic</a><ul style="display: none"><li><a href="218764.htm#_218764" title="Sevikar HCT®">Sevikar HCT®</a></li></ul></li><li id="_129687__129687"><a href="129687.htm#_129687" title="With diuretic">With diuretic</a><ul style="display: none"><li><a href="129688.htm#_129688" title="Olmetec Plus®">Olmetec Plus®</a></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="27526.htm">Previous: LOSARTAN POTASSIUM</a> | <a class="top" href="202472.htm#">Top</a> | <a accesskey="]" href="81217.htm">Next: TELMISARTAN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>